scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.

Follow Up

  • Patients w/ localized scleroderma w/ deep tissue lesions should have an annual monitoring even after treatment cessation as the disease may relapse
  • Prognosis is better w/ localized scleroderma than systemic scleroderma
  • Re-evaluation of symptomatic treatment every 4-6 mths should be done to prevent complications or further deterioration
Editor's Recommendations
Most Read Articles
28 Apr 2019
Women who adopt healthy diets appear to have less severe facial wrinkles, according to a new Dutch study.
01 May 2019
New drug applications approved by US FDA as of 16 - 30 April 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.